Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - roxithromycin -

Arménie - angličtina - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

s.c. sandoz s.r.l. - roxithromycin - tablets film-coated - 150mg

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - roxithromycin -

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - roxithromycin, quantity: 150 mg - tablet, film coated - excipient ingredients: hypromellose; colloidal anhydrous silica; glucose; poloxamer; povidone; maize starch; purified talc; titanium dioxide; magnesium stearate; hyprolose; propylene glycol - for the treatment of mild to moderately severe infections in adults caused by or likely to be caused by susceptible micro-organisms in; acute pharyngitis, tonsillitis, and sinusitis. acute bronchitis and acute exacerbations of chronic bronchitis; community acquired pneumonia (including atypical pneumonia). skin and soft tissue infections and non-gonococcal urethritis

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - roxithromycin, quantity: 150 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; hyprolose; purified talc; magnesium stearate; glucose; titanium dioxide; maize starch; povidone; poloxamer; propylene glycol; hypromellose - adults: for the treatment of mild to moderately severe infections in adults caused by or likely to be caused by susceptible micro-organisms in: acute pharyngitis; tonsillitis and sinusitis. acute bronchitis and acute exacerbations of chronic bronchitis; community acquired pneumonia (including atypical pneumonia). skin and soft tissue infections and non-gonococcal urethritis children: for the treatment of the following mild to moderately severe infections in children caused by or likely to be caused by susceptible micro-organisms: acute pharyngitis; acute tonsillitis; impetigo.

Jordánsko - angličtina - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

الشركة الأردنية لإنتاج الأدوية - jordan pharmaceutical manufacturer (jpm) - roxithromycin 150 mg - 150 mg

Jordánsko - angličtina - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

شركة الرام للصناعات الدوائية - ram pharmaceutical industries co. ltd. - roxithromycin 150 mg - 150 mg

Jordánsko - angličtina - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

شركة الرام للصناعات الدوائية - ram pharmaceutical industries co. ltd. - roxithromycin 150 mg - 150 mg

Jordánsko - angličtina - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

شركة الرام للصناعات الدوائية - ram pharmaceutical industries co. ltd. - roxithromycin 150 mg - 150 mg

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - roxithromycin, quantity: 300 mg - tablet, film coated - excipient ingredients: propylene glycol; povidone; colloidal anhydrous silica; hypromellose; titanium dioxide; sodium starch glycollate type b; sodium starch glycollate type a; maize starch; purified talc; hyprolose; glucose; magnesium stearate; poloxamer - adults: roxithromycin is indicated for the treatment of the following types of mild to moderately severe infections caused by or likely to be caused by susceptible microorganisms: upper respiratory tract infection: acute pharyngitis, tonsillitis and sinusitis. lower respiratory tract infection: acute bronchitis and acute exacerbations of chronic bronchitis; community acquired pneumonia. skin and skin structure infections. nongonococcal urethritis. appropriate culture and sensitivity tests should be performed when necessary to determine organism susceptibility and thus treatment suitability. therapy with roxithromycin may be initiated before results of these tests are known; once results become available, appropriate therapy should be continued.